Monitoring Cardiotoxicity in Patients Receiving VEGF Inhibitors

Cancer Network spoke with Dr. Joerg Herrmann about the importance of detecting and monitoring cardiotoxicity in patients receiving VEGF inhibitors.

Source: CancerNetwork - February 18, 2019 Category: Cancer & Oncology Authors: Joerg Herrmann, MD Source Type: news